Vitargo Athlete Spotlight: Swimming Performance and Recovery, Rio 2016 Interview
- David Barr CSCS, CISSN, RSCC
- May 12, 2017
- 2 min read
FULL Discussion with Rio 2016 Swimmer and Vitargo Athlete Pavel Sankovich. Performance, Recovery, Nutrition, and Training are on the table.
Professional Career Highlights (2006-2016): Pavel Sankovich
A member of Belarus National Team since 2006
Set first national record in 2006 and over 50 throughout the career
Silver and Bronze medalist and Junior World Record holder of 2008 FINA Youth World
Swimming Championships
2008 Olympian (Beijing)
Two times Bronze medalist of 2011 European Short Course Swimming Championships
2012 Olympian (London)
Two times Bronze medalist of 2013 European Short Course Swimming Championships
Bronze medalist of 2014 European Aquatics Championships
Three times Bronze medalist of 2015 European Short Course Swimming Championships
Multiple times national and international competitions winner
Swimming World Cups medalist
2016 Olympian (Rio)
About the Author: David Barr CSCS, CISSN, CSPS, is a performance optimization strategist who combines elements of systems engineering, adaptation physiology, and nutritional biochemistry, resulting in unprecedented levels of confusion. His research experience includes work for NASA at the Johnson Space Center, as well as clinical research on the effect of amino acid intake on muscle growth and recovery. David has authorship in 6 textbook chapters, 4 books, and more than 50 articles on applied training and supplement science. In a transparent act of overcompensation, he has acquired an excess of performance-related certifications, ranging from Tactical Strength and Conditioning to the legal handling of radioactive poison (which is a thing, apparently). He is revered throughout the world for his self-indulgent hyperbole. Contact: David@VitargoS2.com
DISCLAIMER: The opinions expressed are those of the author and do not necessarily reflect those of Vitargo Global Sciences, Inc. These statements have not been evaluated by the Food and Drug Administration.
Comments